FDA issued a Warning Letter to Amgen, Inc. on 5/9/2003 as a result of this inspection.
483 Amgen Jan 2003

483 Amgen Jan 2003

$595.00 - Available Now

FDA investigators audited the Amgen - Boulder, CO, United States facility and issued inspectional observations (via FDA 483) on 24 Jan 2003.

Product details

  • Category: Biologics
  • Inspection end: 24 Jan 2003
  • Location: Boulder, United States
  • FEI: 3003072024
Add To Cart